Abstract:BACKGROUND:One of the major goals in gene and protein expression profiling of cancer is to identify biomarkers and build classification models for prediction of disease prognosis or treatment response. Many traditional statistical methods, based on microarray gene expression data alone and individual genes' discriminatory power, often fail to identify biologically meaningful biomarkers thus resulting in poor prediction performance across data sets. Nonetheless, the variables in multivariable classifiers should synergistically interact to produce more effective classifiers than individual biomarkers.RESULTS:We developed an integrated approach, namely network-constrained support vector machine (netSVM), for cancer biomarker identification with an improved prediction performance. The netSVM approach is specifically designed for network biomarker identification by integrating gene expression data and protein-protein interaction data. We first evaluated the effectiveness of netSVM using simulation studies, demonstrating its improved performance over state-of-the-art network-based methods and gene-based methods for network biomarker identification. We then applied the netSVM approach to two breast cancer data sets to identify prognostic signatures for prediction of breast cancer metastasis. The experimental results show that: (1) network biomarkers identified by netSVM are highly enriched in biological pathways associated with cancer progression; (2) prediction performance is much improved when tested across different data sets. Specifically, many genes related to apoptosis, cell cycle, and cell proliferation, which are hallmark signatures of breast cancer metastasis, were identified by the netSVM approach. More importantly, several novel hub genes, biologically important with many interactions in PPI network but often showing little change in expression as compared with their downstream genes, were also identified as network biomarkers; the genes were enriched in signaling pathways such as TGF-beta signaling pathway, MAPK signaling pathway, and JAK-STAT signaling pathway. These signaling pathways may provide new insight to the underlying mechanism of breast cancer metastasis.CONCLUSIONS:We have developed a network-based approach for cancer biomarker identification, netSVM, resulting in an improved prediction performance with network biomarkers. We have applied the netSVM approach to breast cancer gene expression data to predict metastasis in patients. Network biomarkers identified by netSVM reveal potential signaling pathways associated with breast cancer metastasis, and help improve the prediction performance across independent data sets.

Explainable Machine Learning Models Using Robust Cancer Biomarkers Identification from Paired Differential Gene Expression

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Identification of Differentially Expressed Genes Between Original Breast Cancer and Xenograft Using Machine Learning Algorithms

Heterogeneous Gene Expression Cross-Evaluation of Robust Biomarkers Using Machine Learning Techniques Applied to Lung Cancer

Tumor origin identification through machine learning and gene expression profiling.

Using Machine Learning Methods to Study Colorectal Cancer Tumor Micro-Environment and Its Biomarkers.

Cancer prediction with gene expression profiling and differential evolution

Bimodal gene expression in cancer patients provides interpretable biomarkers for drug sensitivity

Feature Selection and Assessment of Lung Cancer Sub-types by Applying Predictive Models

A Novel Approach to Biomarker Discovery: Four Key Genes as High-Performance Biomarkers for Colorectal Cancer

Identification of Common Microrna-Mrna Regulatory Biomodules in Human Epithelial Cancer

A Comparative Analysis of Gene Expression Profiling by Statistical and Machine Learning Approaches

Towards precision medicine: discovering novel gynecological cancer biomarkers and pathways using linked data

Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response

Cancer Gene Profiling through Unsupervised Discovery

Identifying Cancer Biomarkers by Network-Constrained Support Vector Machines.

Weighted Gene Co-Expression Network Analysis Combined with Machine Learning to Identify Prognostic Biomarkers for Cervical Squamous Cell Carcinoma

Elucidation of dynamic microRNA regulations in cancer progression using integrative machine learning

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

A Cancer Diagnosis Method Combining miRNA-lncRNA Interaction Pairs and Class Weight Competition